by Stem Cell Network | Mar 5, 2012
by Lisa Willemse, with Ubaka Ogbogu and Timothy Caulfield The announcement last week that a team of researchers had identified stem cells responsible for generating human eggs caused a ripple of excitement for several reasons. Not only does the news end a controversy...
by David Kent | Feb 29, 2012
Last week I attended a breakfast at Eversheds, a law firm in Cambridge entitled Stem cell patenting, Brüstle v Greenpeace: business breaker or business as usual? which focused on the practical implications of the recent decision from the Court of Justice of the...
by Lisa Willemse | Feb 1, 2012
Some updates and news items of note: Call for boycott of subscriber-based journals gains momentum The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most...
by Angela C. H. McDonald | Jan 26, 2012
As has been reported broadly this week, transplantation of human embryonic stem cell-derived retinal pigment epithelial cells appears to be safe in human patients, and it may even be efficacious (although this can only be confirmed via a Phase II trial). Advanced Cell...
by Stem Cell Network | Jan 17, 2012
In recent years, the research community has been quite outspoken in its condemnation of rogue stem cell clinics operating in many countries across the globe. Indeed, through announcements made by health and related ministries in China, India and the US, it appears the...
by David Kent | Jan 12, 2012
Last fall, I wrote on the Eurostemcell documentary film entitled Stem Cell Revolutions: A Vision of the Future, which featured some experimental stem cell treatments in India, and since that time, I have tried to keep my finger on the pulse of what has been happening...
Comments